Mergers & Acquisitions

Filter

Current filters:

None

Popular Filters

1 to 25 of 926 results

GSK and Novartis complete major three-part transaction

02-03-2015

UK pharma major GlaxoSmithKline said this morning that its three-part transaction with Swiss peer Novartis…

GlaxoSmithKlineMergers & AcquisitionsNovartisOncologyPharmaceuticalVaccines

AstraZeneca to spin-out early-stage antibiotic R&D into stand-alone company

AstraZeneca to spin-out early-stage antibiotic R&D into stand-alone company

28-02-2015

Anglo-Swedish pharma major AstraZeneca is changing the structure of its small-molecule early-stage anti-infectives…

Antibiotics and Infectious diseasesAstraZenecaMergers & AcquisitionsPharmaceuticalResearchUK

2015 outlook for US and EU pharma; report

2015 outlook for US and EU pharma; report

27-02-2015

According to this Global Pharma US & EU Outlook 2015 report, strategy diversification stays divested…

EuropeManagementMarkets & MarketingMergers & AcquisitionsPatentsPharmaceuticalUSA

Takeda acquires 13 products from Turkish company Neutec

Takeda acquires 13 products from Turkish company Neutec

25-02-2015

Takeda GmbH, the wholly-owned subsidiary of Japanese drugmaker Takeda has signed an agreement to obtain…

Markets & MarketingMergers & AcquisitionsPharmaceuticalTakeda PharmaceuticalTurkey

Shire acquires Meritage Pharma, strengthening rare diseases pipeline

Shire acquires Meritage Pharma, strengthening rare diseases pipeline

24-02-2015

In a second acquisition this year, Ireland-headquartered Shire revealed today that it has taken control…

BiotechnologyGastro-intestinalsMergers & AcquisitionsMeritage PharmaRare diseasesShire

Federal Trade Commission puts conditions on Novartis acquisition of GSK oncology portfolio

Federal Trade Commission puts conditions on Novartis acquisition of GSK oncology portfolio

24-02-2015

The US Federal Trade Commission has put conditions on the proposed acquisition by Novartis of GlaxoSmithKline’s…

Array BioPharmaGSKLegalMergers & AcquisitionsNovartisOncologyPharmaceuticalRegulationResearchUSA

Ipsen pays 6 million euros for option to acquire Canbex

24-02-2015

French drugmaker Ipsen today announced that UK-based biotech firm Canbex Therapeutics has granted an…

BiotechnologyCanbex TherapeuticsIpsenMergers & AcquisitionsNeurologicalVSN16R

Marathon Pharma sells non-strategic products to Valeant

24-02-2015

Marathon Pharmaceuticals, a privately held US biopharmaceuticals company focused on drugs for people…

Marathon PharmaceuticalsMergers & AcquisitionsPharmaceuticalRare diseasesValeant Pharmaceuticals International

Bristol-Myers Squibb to acquire Flexus; inks deal with Rigel

Bristol-Myers Squibb to acquire Flexus; inks deal with Rigel

23-02-2015

US pharma major Bristol-Myers Squibb has signed a definitive agreement to acquire all of the outstanding…

Bristol-Myers SquibbF001287FlexusLicensingMergers & AcquisitionsOncologyPharmaceuticalRigel Pharmaceuticals

Sosei acquires Heptares Therapeutics for up to $400 million

Sosei acquires Heptares Therapeutics for up to $400 million

23-02-2015

Japanese drugmaker Sosei Group says it has acquired Heptares Therapeutics, a clinical-stage private UK-based…

BiotechnologyHeptares TherapeuticsMergers & AcquisitionsNeurologicalRare diseasesSosei

UPDATE: Valeant confirms $10 billion offer for Salix

UPDATE: Valeant confirms $10 billion offer for Salix

23-02-2015

Acquisitive Canadian drugmaker Valeant Pharmaceutical International late Sunday confirmed it has reached…

Gastro-intestinalsMergers & AcquisitionsPharmaceuticalSalix PharmaceuticalsValeant Pharmaceuticals International

Fresenius Kabi sells German oncology compounding business

Fresenius Kabi sells German oncology compounding business

17-02-2015

Fresenius Kabi, a unit of the Germany-headquartered Fresenius Group, has sold its German subsidiary CFL…

CFLFreseniusFresenius KabiGermanyMergers & AcquisitionsNewCo PharmaOncologyPharmaceutical

Intrexon to acquire Belgium's ActoGeniX, bringing new generation of orally-delivered biotherapeutics

13-02-2015

US synthetic biology focussed US firm Intrexon has entered into a definitive agreement to acquire ActoGeniX,…

ActoGeniXBiotechnologyIntrexonMergers & Acquisitions

Actavis to sell its Pharmatech unit to TPG

13-02-2015

Ireland-headquartered generics major Actavis has reached a definitive agreement with TPG, the global…

ActavisAptalis PharmaGenericsMergers & AcquisitionsPharmatech

Julphar takes step into Bangladesh market with RAK Pharma acquisition

Julphar takes step into Bangladesh market with RAK Pharma acquisition

13-02-2015

Julphar, the largest Emirati pharmaceutical company, has acquired a majority stake in Bangladesh drugmaker…

BangladeshGenericsJulpharMergers & AcquisitionsRAK Pharmaceuticals

UPDATE: GSK acquires remainder of GlycoVaxyn for $190 million

UPDATE: GSK acquires remainder of GlycoVaxyn for $190 million

11-02-2015

UK pharma major GlaxoSmithKline this morning said that it has acquired Switzerland-based GlycoVaxyn,…

GlaxoSmithKlineGlycoVaxynMergers & AcquisitionsPharmaceuticalVaccines

No new bidders emerge for Dendreon, so Valeant gets Provenge

No new bidders emerge for Dendreon, so Valeant gets Provenge

11-02-2015

US biotech firm Dendreon revealed yesterday that the bid deadline provided by the Court-approved bidding…

BiotechnologyDendreonMergers & AcquisitionsOncologyProvengeValeant Pharmaceuticals International

Roche acquires Germany’s Signature Diagnostics

Roche acquires Germany’s Signature Diagnostics

10-02-2015

Swiss cancer drugs giant Roche has acquired Signature Diagnostics, a privately-held company based in…

Mergers & AcquisitionsOncologyPharmaceuticalRocheSignature Diagnostics

Cipla enters joint venture in Morocco and eyes Serum Institute of India merger

Cipla enters joint venture in Morocco and eyes Serum Institute of India merger

09-02-2015

Indian pharma company Cipla has announced that its UK subsidiary has entered into a joint venture agreement…

CiplaLicensingMarkets & MarketingMergers & AcquisitionsMoroccoPharmaceutical

Russian government may consider re-purchase from Abbott

09-02-2015

The Russian government may consider the possibility of the re-purchase of the Russian pharmaceutical…

AbbottGenericsMergers & AcquisitionsPoliticsRussiaVeropharm

GlobalData analyst views implications of Pfizer’s acquisition of Hospira

07-02-2015

Just days after gaining US Food and Drug Administration breakthrough approval for Ibrance (palbociclib)…

BiosimilarsHospiraMergers & AcquisitionsPfizerPharmaceutical

Valeant increases its offer to remain lead bidder in Dendreon 'stalking horse' acquisition

Valeant increases its offer to remain lead bidder in Dendreon 'stalking horse' acquisition

05-02-2015

Quebec, Canada-based Valeant Pharmaceuticals has entered into an amended agreement to remain lead bidder…

CanadaDendreonMergers & AcquisitionsPharmaceuticalProvengeValeant

UPDATE: Pfizer to acquire Hospira for around $17 billion

UPDATE: Pfizer to acquire Hospira for around $17 billion

05-02-2015

US pharma giant Pfizer has entered into a definitive merger agreement to acquire Hospira, news of which…

BiosimilarsGenericsHospiraMergers & AcquisitionsPfizer

1 to 25 of 926 results

COMPANY SPOTLIGHT

Menarini

Back to top